Drugs /

cholestyramine

Back to Drugs List

Overview

NCI Definition [1]:
An anion exchange resin with hypolipidemic activity. Cholestyramine resin adsorbs and combines with bile acids in the intestine to form an insoluble complex, which is then excreted in the feces, resulting in an increased oxidation of cholesterol to bile acids, a decrease in low density lipoprotein in the plasma, and a decrease in serum cholesterol levels.

Clinical Trials

View Clinical Trials for cholestyramine

Cholestyramine has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating cholestyramine, 1 is phase 2 (1 open).

Smoldering plasma cell myeloma is the most common disease being investigated in cholestyramine clinical trials [2].

Drug Details

NCIT ID [1]:
C28929

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.